News archive

Researchers at Karolinska Institutet in Sweden have discovered a new and rare skeletal disease. In a study published in the journal Nature Medicine they describe the molecular mechanism of the disease, in which small RNA molecules play a role that has never before been observed in a congenital human disease. The results are important for affected patients but can also help scientists to understand other rare diagnoses.

Professor Sven-Erik Dahlén, IMM, participates in the co-ordination team of the IMI project 3TR that was recently approved for funding by the European Commission.

The workshop ”Build program logic models” for innovations in the programme Let the patients drive! Implementing patient-driven co-care innovations was held on February 12th.

The first Dan Grandér memorial prize for best thesis at Karolinska Institutet in Cancer Research has been awarded to Dr Nicholas Valerie, Department of Oncology-Pathology.

Hello, Galit Andersson, who recently defended a doctoral thesis at the Department of Public Health Sciences, Karolinska Institutet. For your thesis you conducted large surveys of transgender people and people living with HIV in Sweden to assay their quality of life.

Hi there Gylfi Ólafsson! You recently defended your thesis "Health economic aspects of low back pain" at the Department of Learning, Informatics, Management and Ethics. What is it about?​​​​​​​

What happens in the brain when we feel discomfort? Researchers at Karolinska Institutet in Sweden are now one step closer to finding the answer. In a new study published in the journal Molecular Psychiatry they identify which pathways in the mouse brain control behaviour associated with aversion.

Learning what is dangerous by watching a video or being told (known as social learning) has just as strong an effect on our decision-making as first-hand experience of danger, researchers at Karolinska Institutet in Sweden report. The results of the study, which is published in the journal PNAS (Proceedings of the National Academy of Sciences), can help to explain why we take irrational decisions.

Professor Mitchell Lazar at Perelman School of Medicine, University of Pennsylvania, Philadelphia has been selected as recipient of the Rolf Luft Award 2019.

Knowledge of a newly discovered genetic disorder, which means that a person cannot produce the protein TXNIP (thioredoxin interacting protein) in their cells, can open for the development of new diabetes drugs. This is shown in a study from Karolinska Institutet published in the journal Diabetes.

Using puzzle pieces from four different DNA analyses, researchers at Karolinska Institutet have been able to map three extremely complex chromosome aberrations. This has given families answers about the cause of their children’s serious symptoms. The study was published in the scientific journal PLOS Genetics and the goal is to produce a test to be used in the clinic.

New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.

Sara Riggare appointed “Swede of the year in medicine” by Fokus Magazine!

Acute porphyria is a group of uncommon diseases that can cause severe, potentially life-threatening attacks of abdominal pain, nausea, vomiting and paralysis. Liver transplantation is currently the only effective treatment available for the most seriously afflicted patients. A clinical trial conducted in collaboration with researchers at Karolinska Institutet in Sweden now shows that a new drug candidate can prevent attacks in these patients. The study is published in The New England Journal of

Karolinska Microscopic Imaging in Thrombosis & Hemostasis, KARMITH, Core Facility.

For reasons that are unclear, schizophrenia patients have fewer connections between the neurons in the brain. Researchers at Karolinska Institutet, Sweden, and Massachusetts General Hospital, USA, have now succeeded in creating human cell models that show that there is an excessive degradation of connections in the brain of these patients, and they have been able to link this to a genetic risk variant for the disease.

Katja Petzold receives the Swedish Research Council’s consolidator grant for her project “Understanding ribosomal movements to develop new drug targets”.

MTC awards were presented to the following recipients from the Head of Department Susanne Nylén this December.

The research project is led by Ritva Rissanen, postdoc at the Department of Public Health Sciences, and will investigate sick leave patterns when returning to work after a work-related injury, among young adults.

Susanne Nylén has been appointed Head of Department for the Department of Microbiology, Tumor and Cell Biology (MTC).

The courses Leadership and Organization Development 1 (30 credits), course code: 2QA079 and Leadership and Organization Development 2 (30 credits), course code: 2QA203 were given for the last time during 2016/17 and 2017/18.

Professor Klas Kärre at MTC has been awarded the Hilda och Alfred Erikssons Prize for his "important contribution to basic and applied immunology, specializing in tumour, transplantation, and infection immunology research".

Subpopulations of oligodendrocytes, myelin-producing cells in the brain that are targeted by the immune system in multiple sclerosis (MS), are altered in MS and might therefore have additional roles in the disease than previously described. The results are published in the journal Nature, in a study led by researchers at Karolinska Institutet in Sweden and University of Edinburgh in the UK.